121 related articles for article (PubMed ID: 6472603)
1. EEG and clinical findings during pemoline treatment in children and adults with attention deficit disorder. An 8-week open trial.
Caresia L; Pugnetti L; Besana R; Barteselli F; Guareschi Cazzullo A; Musetti L; Scarone S
Neuropsychobiology; 1984; 11(3):158-67. PubMed ID: 6472603
[TBL] [Abstract][Full Text] [Related]
2. Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder.
Zametkin AJ; Linnoila M; Karoum F; Sallee R
Am J Psychiatry; 1986 Mar; 143(3):359-62. PubMed ID: 2420216
[TBL] [Abstract][Full Text] [Related]
3. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
Bostic JQ; Biederman J; Spencer TJ; Wilens TE; Prince JB; Monuteaux MC; Sienna M; Polisner DA; Hatch M
J Child Adolesc Psychopharmacol; 2000; 10(3):205-16. PubMed ID: 11052410
[TBL] [Abstract][Full Text] [Related]
4. Abnormal auditory P300 topography in attention deficit disorder predicts poor response to pemoline.
Sangal JM; Sangal RB; Persky B
Clin Electroencephalogr; 1995 Oct; 26(4):204-13. PubMed ID: 8575100
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents.
Riggs PD; Hall SK; Mikulich-Gilbertson SK; Lohman M; Kayser A
J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):420-9. PubMed ID: 15187802
[TBL] [Abstract][Full Text] [Related]
6. Pemoline in attention deficit disorder and alcoholism: a case study.
Turnquist K; Frances R; Rosenfeld W; Mobarak A
Am J Psychiatry; 1983 May; 140(5):622-4. PubMed ID: 6303137
[TBL] [Abstract][Full Text] [Related]
7. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity.
Collier CP; Soldin SJ; Swanson JM; MacLeod SM; Weinberg F; Rochefort JG
Clin Pharmacokinet; 1985; 10(3):269-78. PubMed ID: 4017397
[TBL] [Abstract][Full Text] [Related]
8. An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder.
Riggs PD; Thompson LL; Mikulich SK; Whitmore EA; Crowley TJ
J Am Acad Child Adolesc Psychiatry; 1996 Aug; 35(8):1018-24. PubMed ID: 8755798
[TBL] [Abstract][Full Text] [Related]
9. Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine.
Sangal JM; Sangal RB; Persky B
Clin Electroencephalogr; 1996 Oct; 27(4):191-201. PubMed ID: 9465283
[TBL] [Abstract][Full Text] [Related]
10. Effect on growth in pemoline-treated children with attention deficit disorder.
Friedmann N; Thomas J; Carr R; Elders J; Ringdahl I; Roche A
Am J Dis Child; 1981 Apr; 135(4):329-32. PubMed ID: 7211792
[TBL] [Abstract][Full Text] [Related]
11. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
[TBL] [Abstract][Full Text] [Related]
12. Pemoline therapy in college students with attention deficit hyperactivity disorder: a retrospective study.
Heiligenstein E; Johnston HF; Nielsen JK
J Am Coll Health; 1996 Jul; 45(1):35-9. PubMed ID: 8708264
[TBL] [Abstract][Full Text] [Related]
13. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
Miller LG; Kraft IA
Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
[TBL] [Abstract][Full Text] [Related]
14. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
Marcus SC; Durkin M
J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):480-9. PubMed ID: 21515197
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline.
Weiss RD; Pope HG; Mirin SM
Drug Alcohol Depend; 1985 May; 15(1-2):69-72. PubMed ID: 4017880
[TBL] [Abstract][Full Text] [Related]
16. Pemoline in ADHD.
Winsberg B; Barbato M
J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
[No Abstract] [Full Text] [Related]
17. Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction.
Conners CK; Taylor E; Meo G; Kurtz MA; Fournier M
Psychopharmacologia; 1972; 26(4):321-36. PubMed ID: 4508756
[No Abstract] [Full Text] [Related]
18. Pemoline and lithium in a patient with attention deficit disorder.
Brown RP; Ingber PS; Tross S
J Clin Psychiatry; 1983 Apr; 44(4):146-8. PubMed ID: 6403515
[No Abstract] [Full Text] [Related]
19. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
Pelham WE; Swanson JM; Furman MB; Schwindt H
J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519
[TBL] [Abstract][Full Text] [Related]
20. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
Rao JK; Julius JR; Breen TJ; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
